
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study
Advertisement
Articles in this issue
over 27 years ago
Optimizing Antimicrobial Therapy and Emerging Pathogensover 27 years ago
Participating Facultyover 27 years ago
Introductionover 27 years ago
Mechanisms and Current Rates of Resistanceover 27 years ago
Influence of Antibiotics on the Normal Floraover 27 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewover 27 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesover 27 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysover 27 years ago
CME QuizAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor
4
Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis
5





